Last reviewed · How we verify
NCT07057635: WISE
Wireless Irradiance SEnsors During Neonatal Phototherapy
trial in Neonatal Hyperbilirubinemia in 6 participants. Not yet recruiting.
10 September 2025
Quick facts
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 6 |
| Start date | 10 July 2025 |
| Primary completion | 10 September 2025 |
| Estimated completion | 10 September 2025 |
Conditions studied
- Neonatal Hyperbilirubinemia — all drugs for Neonatal Hyperbilirubinemia →
- Jaundice, Neonatal — all drugs for Jaundice, Neonatal →
- Phototherapy Complication — all drugs for Phototherapy Complication →
- Newborn Complication — all drugs for Newborn Complication →
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Who can join
Eligibility, any sex, with Neonatal Hyperbilirubinemia or Jaundice, Neonatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bilisensors are devices designed to measure the cumulative dose of phototherapy administered to neonates undergoing treatment for hyperbilirubinemia. The current standard of care typically involves intermittent spot measurements once a day using a handheld dosimeter that may give variable estimations. In contrast, bilisensors may enable continuous, real-time monitoring of light exposure, helping to know the total phototherapy dose received by the infant.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07057635
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Hyperbilirubinemia
Currently open trials in the same condition.
- NCT07346976 — Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-D · NA · recruiting
- NCT06832800 — Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH · EARLY_PHASE1 · recruiting
- NCT06702241 — Newborn Jaundice - An Investigation of Different Approaches to Light Therapy · Phase 2, PHASE3 · recruiting
- NCT06687746 — Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns · active not recruiting
- NCT06517862 — Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia · Phase 4 · recruiting
Other McGill University Health Centre/Research Institute of the McGill University Health Centre trials
Trials by the same sponsor.
- NCT07439406 — Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy · Phase 2 · not yet recruiting
- NCT07328971 — Vancomycin Taper to Prevent Recurrent Clostridioides Difficile · Phase 3 · not yet recruiting
- NCT07556952 — Dex & Mastectomy Pain · Phase 4 · recruiting
- NCT07069582 — Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women · Phase 1 · not yet recruiting
- NCT07386171 — Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07057635 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre
- Last refreshed: 10 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07057635.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing